Autopsy of Fatal Delta Variant in a Fully Vaccinated Man
Findings Suggest Complete Failure of Pfizer-BioNTech COVID-19 Vaccine Induced Antibodies
By Peter A. McCullough, MD, MPH
Autopsies have played a critical role in the history of medicine. The novel coronavirus pandemic is a period of time where autopsies have been particularly helpful in advancing our understanding of COVID-19 disease. So the question on the table is: if the mRNA COVID-19 vaccines raised antibodies against the ancestral wild type Wuhan strain of SARS-CoV-2, would they cover the Delta variant? The only real way to know is to find a case who is fully vaccinated with “protective” antibodies in the bloodstream who contracts COVID-19. Recently such a patient has been reported from Catania, Italy.
Esposito, et al, published an autopsy of an 83 year old man who was admitted to the hospital with heart failure and was later diagnosed with acute COVID-19 and succumbed 18 days later. There is no mention of treatment with lifesaving medications in the McCullough protocol such as ivermectin, corticosteroids, or anticoagulants. Sadly his lungs were ravaged with SARS-CoV-2 despite having adequate antibody titers for the Spike protein generated from the Pfizer-BioNTech COVID-19 Vaccine.
The important points of this paper are: 1) the original Pfizer-BioNTech COVID-19 Vaccine failed to stop the Delta variant, 2) antibodies are an invalid surrogate of protection and should have never been used 8 times by the US FDA in EUA approvals for extended use of COVID-19 vaccines.
If you find “Courageous Discourse” enjoyable and useful to your endeavors, please subscribe as a paying or founder member to support our efforts in helping you engage in these discussions with family, friends, and your extended circles.
I have been suspicious from the start about the apparent refusal by authorities to conduct autopsies in the US. I see it to be a strong clue as to the coverup and deception.
There was a bill passed in NZ late last year to allow for more causes of death to be unknown.